MARKET

NVIV

NVIV

Invivo Therapeut
NASDAQ
0.7501
-0.0494
-6.18%
After Hours: 0.7650 +0.0149 +1.99% 19:13 12/08 EST
OPEN
0.7850
PREV CLOSE
0.7995
HIGH
0.8300
LOW
0.7205
VOLUME
16.09K
TURNOVER
0
52 WEEK HIGH
2.800
52 WEEK LOW
0.6015
MARKET CAP
2.33M
P/E (TTM)
-0.2128
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Wednesday's Intraday Session
Sera prognostics stock increased by 231.9% to $6.97 during wednesday's regular session. Syros pharmaceuticals stock moved upwards by 45.03%. Altimmune shares rose 39.94% and phio pharma shares increased by 60.36% during the session.
Benzinga · 3d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Phio pharma shares moved upwards by 19.6% to $1.34 during tuesday's after-market session. Aclaris therapeutics (nasdaq:acrs) stock moved up by 8.47%. Lucy scientific discovery (nasdaq:lsdi) shares rose by 9.34%.
Benzinga · 4d ago
Weekly Report: what happened at NVIV last week (1127-1201)?
Weekly Report · 6d ago
Invivo Therapeut: Current report
Press release · 12/02 00:04
Invivo Therapeut: Current report
Press release · 11/30 17:03
Weekly Report: what happened at NVIV last week (1120-1124)?
Weekly Report · 11/27 09:51
Invivo Therapeut: Current report
Press release · 11/23 00:02
Weekly Report: what happened at NVIV last week (1113-1117)?
Weekly Report · 11/20 09:50
More
About NVIV
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (SCIs). The Company's Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. It is intended to promote appositional, or side-by-side, healing by supporting the surrounding tissue after injury, minimizing the expansion of areas of necrosis, and providing a biomaterial substrate for the body's own healing/repair processes following injury. It is composed of two biocompatible and bioresorbable polymers that are cast to form a porous investigational product: Poly lactic-co-glycolic acid and Poly-L-Lysine. Poly lactic-co-glycolic acid is a polymer that is used in resorbable sutures and provides biocompatible support for Neuro-Spinal Scaffold implants and Poly-L-Lysine is a positively charged polymer used to coat surfaces.

Webull offers Invivo Therapeutics Holdings Corp stock information, including NASDAQ: NVIV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVIV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVIV stock methods without spending real money on the virtual paper trading platform.